← Human Trials & Peer-Reviewed Studies
A comparison of pituitary-adrenal responses to corticotropin-releasing hormone, hypoglycaemia and metyrapone in children with brain tumours and growth hormone deficiency
Plain-language guide to PMID 8582421 (1995): clinical trial study of ACTH (Corticotropin) and CRH (Corticotropin-Releasing Hormone).
Key Facts
- PMID
- 8582421
- Journal
- European journal of pediatrics
- Year
- 1995
- Study type
- Clinical Trial
- Authors
- Fujiwara I et al. (3 authors)
- DOI
- 10.1007/BF02276714
What This Study Did, in Plain Language
What Was Tested
This clinical trial paper looks at ACTH (Corticotropin) and CRH (Corticotropin-Releasing Hormone).
To assess hypothalamic-pituitary function, a corticotropin-releasing hormone (CRH) stimulation test was performed in nine children following treatment for brain tumours and in 27 growth hormone deficient (GHD) children whose pituitary adrenocorticotropin (ACTH) secretion was normal.
Why It Was Studied
In both groups, CRH tests were compared with ACTH and cortisol responses to insulin-induced hypoglycaemia and with ACTH response to metyrapone stimulation.
In the patients with brain tumours (five craniopharyngiomas, two suprasellar germinomas, one cerebellar medulloblastoma and one cerebellar ependymoma), ACTH responses to CRH varied greatly with absent or blunted, normal, and exaggerated reactions.
Who Took Part
PubMed indexes the participants as young children, children and teenagers, both men and women.
What Was Measured
In both groups, CRH tests were compared with ACTH and cortisol responses to insulin-induced hypoglycaemia and with ACTH response to metyrapone stimulation.
In GHD children but not in children with brain tumours the responses to CRH, insulin tolerance test and metyrapone test were correlated.
PubMed files the paper under topics including Adrenocorticotropic Hormone, Brain Neoplasms, Corticotropin-Releasing Hormone, Craniopharyngioma, Growth Hormone, Hydrocortisone and Metyrapone.
What This Means in Plain Language
This is a clinical trial of ACTH (Corticotropin) and CRH (Corticotropin-Releasing Hormone).
Its findings take up roughly 2 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.
The publication is from 1995 (European journal of pediatrics), a journal based in Germany.
More context: the ACTH (Corticotropin) compound page and the CRH (Corticotropin-Releasing Hormone) compound page, all human trials.
Our Notes on the Compounds
ACTH (Corticotropin): The 39-amino-acid pituitary hormone that drives cortisol production; given as repository corticotropin (Acthar Gel).
CRH (Corticotropin-Releasing Hormone): The 41-amino-acid hypothalamic hormone that triggers ACTH release; corticorelin is used diagnostically.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.